NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
Clinical Trials
22 trialsNCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT05086770 2023-07-14
Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
Next Biomedical Co., Ltd.
Phase NA Completed
NCT01735812 2022-06-13
UFREEZE-01
IceCure Medical Ltd.
Phase NA Withdrawn
NCT04672421 2021-09-29
The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)
Shin Poong Pharmaceutical Co. Ltd.
Phase NA Completed
NCT02520414 2021-03-26
Symphion® System In-Office Study
Minerva Surgical, Inc.
Phase NA Completed
NCT01338831 2020-12-17
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
Novartis
Phase 1 Completed
NCT03744507 2020-11-10
Bone Mineral Density in Women With Uterine Fibroids or Endometriosis
Myovant Sciences GmbH
Completed
NCT03535610 2020-09-04
EMBOSOFT I
Scitech Produtos Medicos SA
Phase NA Completed
NCT00295217 2018-12-20
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
InSightec
Phase 3 Completed
NCT03550703 2018-07-06
V3-myoma
Immunitor LLC
Phase 2 Unknown
NCT03219385 2018-03-21
DIANA
Mirabilis Medica, Inc.
Phase NA Unknown
NCT03156127 2017-08-10
A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
Boryung Pharmaceutical Co., Ltd
Phase 1 Withdrawn
NCT01504308 2017-04-05
SOFIA
Philips Healthcare
Phase 2/3 Terminated
NCT01588899 2015-10-22
China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids
Philips Healthcare
Phase NA Completed
NCT01069094 2014-06-30
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Repros Therapeutics Inc.
Phase 1/2 Completed
NCT00837161 2012-12-04
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
Philips Healthcare
Phase 1/2 Completed
NCT00897897 2012-12-04
Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids
Philips Healthcare
Phase NA Completed
NCT01064960 2012-12-04
Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner
Philips Healthcare
Phase 3 Completed
NCT01141062 2012-12-04
HIFU
Philips Healthcare
Phase 3 Completed
NCT00444704 2009-07-10
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed
NCT00826436 2009-03-06
Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer
Completed